Literature DB >> 31985279

L-glutamine for sickle cell disease: Knight or pawn?

Alina Sadaf1, Charles T Quinn1,2.   

Abstract

Keywords:  L-glutamine; Sickle cell disease; clinical trials; glutamine; reactive oxygen species; sickle cell anemia

Mesh：

Substances：

Year:  2020        PMID： 31985279      PMCID： PMC7016414          DOI： 10.1177/1535370219900637

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  84 in total

Review 1.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.

Authors:  F Q Schafer; G R Buettner
Journal:  Free Radic Biol Med       Date:  2001-06-01       Impact factor: 7.376

2.  Safety and metabolic effects of L-glutamine administration in humans.

Authors:  T R Ziegler; K Benfell; R J Smith; L S Young; E Brown; E Ferrari-Baliviera; D K Lowe; D W Wilmore
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Jul-Aug       Impact factor: 4.016

3.  Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress.

Authors:  V L Tatum; C K Chow
Journal:  Free Radic Res       Date:  1996-08

4.  The effect of glutamine supplementation on athletic performance, body composition, and immune function: A systematic review and a meta-analysis of clinical trials.

Authors:  Amirhossein Ramezani Ahmadi; Elham Rayyani; Mehdi Bahreini; Anahita Mansoori
Journal:  Clin Nutr       Date:  2018-05-09       Impact factor: 7.324

Review 5.  Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine.

Authors:  Claudia R Morris; Jill Hamilton-Reeves; Robert G Martindale; Menaka Sarav; Juan B Ochoa Gautier
Journal:  Nutr Clin Pract       Date:  2017-02-01       Impact factor: 3.080

6.  Glutamine plays a role in superoxide production and the expression of p47phox, p22phox and gp91phox in rat neutrophils.

Authors:  Tania Cristina Pithon-Curi; Adriana C Levada; Lúcia R Lopes; Sonia Q Doi; Rui Curi
Journal:  Clin Sci (Lond)       Date:  2002-10       Impact factor: 6.124

7.  Oral glutamine supplementation decreases resting energy expenditure in children and adolescents with sickle cell anemia.

Authors:  Ruth Williams; Stacie Olivi; Chin-Shang Li; Michael Storm; Lola Cremer; Paul Mackert; Winfred Wang
Journal:  J Pediatr Hematol Oncol       Date:  2004-10       Impact factor: 1.289

8.  Oral glutamine in paediatric oncology patients: a dose finding study.

Authors:  E Ward; S Picton; U Reid; D Thomas; C Gardener; M Smith; M Henderson; V Holden; S Kinsey; I Lewis; V Allgar
Journal:  Eur J Clin Nutr       Date:  2003-01       Impact factor: 4.016

9.  Up-regulation of NADPH oxidase components and increased production of interferon-gamma by leukocytes from sickle cell disease patients.

Authors:  Lívia E Marçal; Péricles M Dias-da-Motta; Jussara Rehder; Ronei L Mamoni; Maria Heloísa S L Blotta; Constance B Whitney; Peter E Newburger; Fernando F Costa; Sara T O Saad; Antonio Condino-Neto
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

10.  Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet.

Authors:  J Lyons; A Rauh-Pfeiffer; Y M Yu; X M Lu; D Zurakowski; R G Tompkins; A M Ajami; V R Young; L Castillo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205
View more
  6 in total

1.  Advances in the Management of Sickle Cell Disease: New Concepts and Future Horizons.

Authors:  Tara Higgins; Melissa A Menditto; Stephanie Katartzis; Kelly L Matson
Journal:  J Pediatr Pharmacol Ther       Date:  2022-03-21

Review 2.  Complement in Sickle Cell Disease: Are We Ready for Prime Time?

Authors:  Eleni Gavriilaki; Efthymia Vlachaki; Christos Varelas; Athina Tampaki; Ioanna Sakellari; Αchilles Anagnostopoulos
Journal:  J Blood Med       Date:  2021-03-23

Review 3.  In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System.

Authors:  Alba Saenz de Villaverde Cortabarria; Laura Makhoul; John Strouboulis; Giovanna Lombardi; Eugene Oteng-Ntim; Panicos Shangaris
Journal:  Front Cell Dev Biol       Date:  2021-01-22

4.  Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients.

Authors:  Narcisse Elenga; Gylna Loko; Maryse Etienne-Julan; Randa Al-Okka; Ahmad M Adel; Mohamed A Yassin
Journal:  Front Med (Lausanne)       Date:  2022-08-01

Review 5.  Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.

Authors:  Walufu Ivan Egesa; Gloria Nakalema; William M Waibi; Munanura Turyasiima; Emmanuel Amuje; Gloria Kiconco; Simon Odoch; Patrick Kumbowi Kumbakulu; Said Abdirashid; Daniel Asiimwe
Journal:  Int J Pediatr       Date:  2022-10-08

Review 6.  Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic.

Authors:  Faisal Alsayegh; Shaker A Mousa
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.